Helixgate

Helixgate

Helixgate

Helixgate

Press & Media — Helixgate Biotech Review

A global intelligence platform covering biotechnology innovation, advanced computational systems, and strategic developments across the life sciences ecosystem.

Request Media Access
Download Media Kit

About Helixgate Biotech Review

Helixgate Biotech Review is a high-tech intelligence publication focused on the companies, technologies, and capital shaping the future of biotechnology and life sciences.
We deliver executive-level intelligence across drug discovery, artificial intelligence, advanced computational systems, and global pharmaceutical strategy.

Our platform is designed to provide high-signal insights, strategic visibility, and industry positioning for companies operating at the forefront of innovation.

Our platform is designed to provide high-signal insights, strategic visibility, and industry positioning for companies operating at the forefront of innovation.

Editorial Coverage Areas

Artificial Intelligence & Computational Systems

Coverage of AI-driven research, machine learning applications, and advanced computational infrastructure shaping biotech innovation.

Drug Discovery & Therapeutics

Insights into emerging therapies, discovery platforms, and next-generation treatment development.

Biotech Capital & Strategic Intelligence

Analysis of funding, partnerships, capital flows, and strategic positioning across the biotech sector.

Event Coverage & Media Access

Helixgate Biotech Review provides on-site and post-event intelligence coverage across leading biotechnology and pharmaceutical conferences globally.

Coverage includes:

  • Founder and executive interviews
  • Technology and innovation briefings
  • Strategic partnership insights
  • Company feature highlights
  • Investor-focused intelligence distribution
Helixgate coverage is designed to extend event visibility beyond the conference floor—delivering exposure to a targeted audience of biotech decision-makers, investors, and industry leaders.

Why Events Partner with Helixgate

  • Targeted exposure to biotech and pharmaceutical decision-makers
  • Executive-level intelligence coverage and distribution
  • Strategic visibility for participating companies and technologies
  • Post-event amplification across a growing global audience

Platform Overview

Helixgate operates at the intersection of scientific innovation, computational systems, and capital markets.

We connect biotech companies, pharmaceutical organizations, research institutions, and investors through intelligence-driven content, strategic exposure, and partnership visibility.

Audience & Reach

20,000 – 30,000

Organizations

100,000 – 300,000

Decision-Makers

Audience includes founders, researchers, executives, investors, and decision-makers across the global biotechnology ecosystem.

Strategic Positioning

Helixgate Biotech Review is not a traditional media outlet. It operates as a digital intelligence platform designed to highlight emerging technologies, industry shifts, and high-value opportunities across the biotech ecosystem.
We also engage with select companies on strategic visibility and partnership intelligence initiatives following event coverage.

Press & Media Inquiries

For press credentials, conference coverage, interview requests, and media inquiries, please contact our press office.

Press Contact

press@helixgatebiotechreview.com

Coverage Areas

  • Media credentials
  • Interview requests
  • Event coverage
  • Strategic media partnerships